Resources - Announcements

Announcements

Update to Fingernail Collection Update to Fingernail Collection

6-Oct-2016

To help you have the best possible solutions that science can offer, we are consistently evaluating our processes to keep them ahead of the curve. As science progresses, so do our capabilities. Because of such progress, we have some important updates to the fingernail collection process.

Update to Meconium Collection Update to Meconium Collection

12-Aug-2016

To help you have the best possible solutions that science can offer, we are consistently evaluating our processes to keep them ahead of the curve. As science progresses, so do our capabilities. Because of such progress, we have some important updates to the meconium collection process.

Report Change Notification Report Change Notification

18-Apr-2016

Effective July 18, 2016, USDTL will be implementing a new way of reporting quantitative results. In order to satisfy accreditation requirement, the concentrations of drugs exceeding the Upper Limit of Quantification (ULOQ) for any given drug will be reported as > ULOQ (greater than ULOQ). The ULOQ will be provided.

Quantity Not Sufficient (QNS) Explained Quantity Not Sufficient (QNS) Explained

02-Mar-2016

Quantity Not Sufficient (QNS) is a result of not having a sufficient quantity (volume) of
specimen to test for the panels ordered. The amount of specimen required for collection
is directly related to the amount of specimen needed to screen and confirm for the panels we offer. The initial screening uses a portion of the original specimen and the confirmation testing uses another portion of the original specimen. To forensically confirm positives, means running a new test, with a new portion of the original specimen, using a different analytical technique.

Antihistamines and OTC Amphetamines to be Discontinued in Urine Antihistamines and OTC Amphetamines to be Discontinued in Urine

01-Feb-2016

We are writing to notify our clients that effective February 1, 2016, we will no longer be testing urine for antihistamines and OTC amphetamines. We apologize for any inconvenience this may cause.

USDTL is now ISO/IEC 17025 Accredited USDTL is now ISO/IEC 17025 Accredited

22-Sep-2015

We are proud to announce that we are the first laboratory in the world to be ISO/IEC 17025 accredited for drug and alcohol testing in umbilical cord, fingernail, and toenail specimens. On September 4, 2015, USDTL attained ISO/IEC 17025 accreditation showing full compliance with the international testing standards. We have received our accreditation from ANSI-ASQ National Accreditation Board, demonstrating technical competence in the field of forensic testing. The scope of our ISO/IEC 17025 accreditation encompasses all specimen types and methods of analysis utilized in our laboratory.

Sevoflurane Discontinued Sevoflurane Discontinued

27-Aug-2015

We are writing to notify our clients that, effective October 1, 2015, we will no longer be offering Sevoflurane as a testing option.

Oral Fluid Discontinued Oral Fluid Discontinued

27-Aug-2015

We are writing to notify our clients that, effective October 1, 2015, we will no longer be offering Oral Fluid specimen testing.

Cutoffs for Antihistamine Drugs in Urine Lowered Cutoffs for Antihistamine Drugs in Urine Lowered

3-Aug-2015

I am pleased to inform you that USDTL has succeeded in improving our urine assay for antihistamine drugs by reducing the cutoff from 500 ng/mL to 100 ng/mL. The improved urine assay for antihistamine drugs will be available starting August 3, 2015.

Updated Policy Regarding Insufficient Specimen Volumes Updated Collection Instructions Updated Policy Regarding Insufficient Specimen Volumes Updated Collection Instructions

1-Apr-2015

It is our first priority to deliver testing results that provide the most valuable information possible for your substance abuse testing needs. To better accomplish this duty to our clients, we are updating our policy concerning specimens that do not have sufficient volume for both preliminary testing and confirmation. Effective April 1, 2015, confirmatory tests that cannot be completed due to insufficient specimen volume will be canceled on an individual drug class and/or analyte basis. We will report confirmation results for each test for which there is sufficient volume of specimen available, giving you access to more information.

Changes to Fingernail Collection Procedures Changes to Fingernail Collection Procedures

27-Feb-2015

It is USDTL's mission to use the best science available to provide cutting edge tools for the detection of alcohol and substances of abuse. To better accomplish our mission, we are updating our collection procedures for fingernail specimens. Effective March 1, 2015, cosmetic treatments of any kind must be removed from fingernail specimens prior to being submitted to USDTL for testing. Specimens received with cosmetic treatments still applied to them will be rejected and will not be processed. Cosmetic treatments include artificial acrylic, gel or silk overlays; nail polish; basecoats; topcoats; hardeners; and any application to the nail that is not the natural nail material. When removing fingernail polish prior to collection, a non-ethanol based polish remover should be used.

USDTL Develops Assay to Detect Zolpidem (Ambien®) in Fingernails and Hair USDTL Develops Assay to Detect Zolpidem (Ambien®) in Fingernails and Hair

01-Oct-2014

Des Plaines, IL - United States Drug Testing Laboratory, Inc. (USDTL), a forensic laboratory specializing in drug and alcohol testing using advanced specimens, has released a new assay to detect zolpidem (Ambien®) use in fingernail and hair specimens. Previously available only in urine and oral-fluid specimens, zolpidem testing in fingernails and hair offers forensic drug testing professionals new, powerful tools to meet their drug testing needs.

Improved Screening Assay For Buprenorphine in Umbilical Cord Improved Screening Assay For Buprenorphine in Umbilical Cord

01-Jul-2014

USDTL has succeeded in improving their umbilical cord screening assay for buprenorphine by reducing the positive result cutoff from 1.0 ng/g down to 0.5 ng/g. The improved umbilical cord buprenorphine assay gives the best possible detection of buprenorphine exposure, making it possible to identify more newborns exposed to buprenorphine in utero.

Laboratory First to Obtain Specimens from the Virtual Repository of Dried Blood Spots Laboratory First to Obtain Specimens from the Virtual Repository of Dried Blood Spots

14-Jun-2013

USDTL is the first laboratory to be awarded specimens from the Virtual Repository of Dried Blood Spots, a new national database of dried blood spot specimens available for use in research.

Laboratory Improves Propofol Testing Following New Research Data Laboratory Improves Propofol Testing Following New Research Data

05-Jul-2013

New data from researchers at USDTL shows that propofol use can be detected in urine samples for as long as 28 days following low-dose anesthesia.

Laboratory Awarded NIAAA Funding to Investigate The Epigenetics of Prenatal Alcohol Exposure Laboratory Awarded NIAAA Funding to Investigate The Epigenetics of Prenatal Alcohol Exposure

04-Nov-2013

USDTL researchers will investigate the relationship between in utero alcohol exposure and epigenetics using Small Business Innovation Research funding from the National Institute on Alcohol Abuse and Alcoholism.




contact USDTL

1.800.235.2367

Newsletters, Posters, and Catalogs

Our print materials will keep you up to date on the latest news in drug and alcohol testing.

Request Literature

Request Your Collection Supplies

For your convenience, USDTL provides test collection supplies at no additional charge.

Order Supplies

Resources

View Resources
0